NPNarae Park

Narae Park

*This is an algorithmically generated author record based on publicly available information.

Narae Park has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Ji Hyeon Ju

    Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    6 shared publications
  • Yeri Alice Rim

    CiSTEM laboratory, Convergent Research Consortium for Immunologic Disease, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    6 shared publications
  • Yoojun Nam

    YiPSCELL Inc., Seoul, Republic of Korea

    3 shared publications
  • Jennifer Lee

    Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    2 shared publications
  • Sung-Hwan Park

    Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

    2 shared publications
  • Chang Pyo Hong

    YiPSCELL Inc., Seoul, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Clinical-grade iPSC-derived chondrogenic micropellets for treating advanced cartilage defects

    by Yoojun Nam, Narae Park, Jinhyeok Choi, Kijun Lee, Si Hwa Choi, Jang-Woon Kim, SeonJu Choi, Chang Pyo Hong, Jennifer Lee, Joon-Yong Jung, et al.

    Induced pluripotent stem cell (iPSC)–derived chondrogenic tissues represent a promising alternative for treating cartilage defects in chronic degenerative joint conditions such as osteoarthritis (OA). Cartilage tissue has limited self-repair capacity, and although allogeneic transplantation has potential, a less invasive delivery method could enhance the efficacy of cell-based therapies. The aim of this study was to develop iPSC-derived “minimal injectable unit” chondrogenic micropellets (MIUChons) for delivery via intra-articular injections for OA therapy. To create transplantable allogeneic cartilage tissue, we optimized good manufacturing practice or clinical-grade production of iPSC-derived injectable chondrogenic spheroids and tested them in OA animal models. MIUChons were delivered to damaged cartilage through a single injection. In vivo and in vitro analyses demonstrated that MIUChon treatment effectively reduced cartilage degeneration and deterioration. In addition, injecting MIUChons into the intra-articular cavity improved arthritis symptoms. Overall, MIUChons offer a strategy for treating cartilage deterioration via intra-articular injection in patients with OA.


  • Open Access

    iPSC‐Derived MSC Secretome as a Protective and Restorative Modality for Atopic Dermatitis

    by Seungah Yoo, Hyun Jin Baek, Narae Park, Yoojun Nam, Yeri Alice Rim, Ji Hyeon Ju

    Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease that significantly impacts quality of life. Reducing inflammation and restoring the skin barrier are key to its management. Objective: This study aimed to investigate the protective and therapeutic effects of secretory substances from induced pluripotent stem cell (iPSC)‐derived mesenchymal stem cells (iMSCs) in AD. Methods: The protective effects of iMSC secretome pretreatment were evaluated in HaCaT cells by assessing cell viability, AD biomarker expression, and cell migration. Therapeutic efficacy was examined in a 1‐chloro‐2,4‐dinitrobenzene (DNCB)‐induced AD mouse model through clinical, histological, and immunological assessments. Proteomic analyses were performed to relevant biological processes. Results: iMSC secretome significantly reduced AD‐induced cell death and AD biomarker expressions in vitro ( p < 0.05), with 200 μg/mL iMSC secretome promoting cell migration. In vivo, high dose (20 mg/mL) iMSC secretome alleviate clinical indicators compared to the vehicle group ( p < 0.05). Serum immunoglobulin (Ig) E, interleukin (IL)‐4, IL‐31, and IL‐6 levels, along with the expression of AD biomarkers in skin, were significantly decreased ( p < 0.05). Proteomic analyses revealed upregulation of genes involved in the regulation of immune responses and the restoration of skin barrier. Conclusion: iMSC secretome demonstrates significant anti‐inflammatory and regenerative effects, making it a promising therapeutic option for AD.

  • Open Access

    Sodium Chloride Aggravates Arthritis via Th17 Polarization

    by Seung Min Jung, Youngkyun Kim, Juryun Kim, Hyerin Jung, Hyoju Yi, Yeri Alice Rim, Narae Park, Seung-Ki Kwok, Sung-Hwan Park, Ji Hyeon Ju

    Jung SM, et al. Yonsei Med J. 2019 Jan;60(1):88-97. https://doi.org/10.3349/ymj.2019.60.1.88


  • Repair potential of nonsurgically delivered induced pluripotent stem cell-derived chondrocytes in a rat osteochondral defect model

    by Yeri Alice Rim, Yoojun Nam, Narae Park, Jennifer Lee, Sung-Hwan Park, Ji Hyeon Ju

    Human induced pluripotent stem cells (hiPSCs) are thought to be an alternative cell source for future regenerative medicine. hiPSCs may allow unlimited production of cell types that have low turnover rates and are difficult to obtain such as autologous chondrocytes. In this study, we generated hiPSC‐derived chondrogenic pellets, and chondrocytes were isolated. To confirm the curative effects, chondrogenic pellets and isolated chondrocytes were transplanted into rat joints with osteochondral defects. Isolated hiPSC‐derived chondrocytes were delivered in the defect by a single intra‐articular injection. The generated hiPSC‐derived chondrogenic pellets had increased chondrogenic marker expression and accumulated extracellular matrix proteins. Chondrocytes were successfully isolated from the pellets. Alcian blue staining and collagen type II were detected in the cells. Chondrogenic marker expression was also increased in the isolated cells. Transplanted chondrogenic pellets and chondrocytes both had curative effects in the osteochondral defect rat model. Detection of human proteins in the joints proved that the cells were successfully delivered into the defect. Chondrogenic pellets or chondrocytes generated from hiPSCs have potential as regenerative medicine for cartilage recovery or regeneration. Chondrocytes isolated from hiPSC‐derived chondrogenic pellets had curative effects in damaged cartilage. Injectable hiPSC‐derived chondrocytes show the possibility of noninvasive delivery of regenerative medicine for cartilage recovery.


  • Open Access

    Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells

    by Yeri Alice Rim, Yoojun Nam, Narae Park, Hyerin Jung, Yeonsue Jang, Jennifer Lee, Ji Hyeon Ju

    Scientists have tried to reprogram various origins of primary cells into human induced pluripotent stem cells (hiPSCs). Every somatic cell can theoretically become a hiPSC and give rise to targeted cells of the human body. However, there have been debates on the controversy about the differentiation propensity according to the origin of primary cells. We reprogrammed hiPSCs from four different types of primary cells such as dermal fibroblasts (DF,n=3), peripheral blood mononuclear cells (PBMC,n=3), cord blood mononuclear cells (CBMC,n=3), and osteoarthritis fibroblast-like synoviocytes (OAFLS,n=3). Established hiPSCs were differentiated into chondrogenic pellets. All told, cartilage-specific markers tended to express more by the order of CBMC > DF > PBMC > FLS. Origin of primary cells may influence the reprogramming and differentiation thereafter. In the context of chondrogenic propensity, CBMC-derived hiPSCs can be a fairly good candidate cell source for cartilage regeneration. The differentiation of hiPSCs into chondrocytes may help develop “cartilage in a dish” in the future. Also, the ideal cell source of hiPSC for chondrogenesis may contribute to future application as well.


  • Open Access

    The Generation of Human Induced Pluripotent Stem Cells from Blood Cells: An Efficient Protocol Using Serial Plating of Reprogrammed Cells by Centrifugation

    by Youngkyun Kim, Yeri Alice Rim, Hyoju Yi, Narae Park, Sung-Hwan Park, Ji Hyeon Ju

    Human induced pluripotent stem cells (hiPSCs) have demonstrated great potential for differentiation into diverse tissues. We report a straightforward and highly efficient method for the generation of iPSCs from PBMCs. By plating the cells serially to a newly coated plate by centrifugation, this protocol provides multiple healthy iPSC colonies even from a small number of PBMCs. The generated iPSCs expressed pluripotent markers and differentiated into all three germ layer lineages. The protocol can also be used with umbilical cord blood mononuclear cells (CBMCs). In this study, we present a simple and efficient protocol that improved the yield of iPSCs from floating cells such as PBMCs and CBMCs by serial plating and centrifugation.